Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Aus-131. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 known ✓ | Q92731 | 7/20 | 1.00 |
| ▸ | ESR1 | P03372 | 6/20 | 1.00 |
| ▸ | TTR | P02766 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 7/20 | 0.74 |
| ▸ | ALOX12 | P18054 | 6/20 | 0.74 |
| ▸ | ALOX15B | O15296 | 3/20 | 0.74 |
| ▸ | RARA | P10276 | 1/20 | 0.45 |
| ▸ | RARB | P10826 | 1/20 | 0.45 |
| ▸ | RARG | P13631 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aus-131 SCHEMBL677723 | 1.00 | ESR2 (1.00) | ESR2ESR1TTRALOX15ALOX12 | |
| Aus-131 SCHEMBL29467332 | 1.00 | ESR2 (1.00) | ESR2ESR1TTRALOX15ALOX12 | |
| Aus-131 SCHEMBL2002128 | 1.00 | ESR2 (1.00) | ESR2ESR1TTRALOX15ALOX12 | |
| Aus-131 SCHEMBL43647 | 1.00 | ESR2 (1.00) | ESR2ESR1TTRALOX15ALOX12 | |
| Aus-131 SCHEMBL17591903 | 0.91 | ESR2 (0.83) | ESR2ESR1TTRALOX15ALOX12 | |
| SCHEMBL31545730 | 0.91 | ESR2 (0.83) | ESR2ESR1TTRALOX15ALOX12 | |
| SCHEMBL19861143 | 0.91 | ESR2 (0.83) | ESR2ESR1TTRALOX15ALOX12 | |
| SCHEMBL17679253 | 0.91 | ESR2 (0.83) | ESR2ESR1TTRALOX15ALOX12 | |
| SCHEMBL30720187 | 0.90 | ESR2 (0.82) | ESR2ESR1TTRALOX15ALOX12 | |
| SCHEMBL4360255 | 0.90 | ESR2 (0.82) | ESR2ESR1TTRALOX15ALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6053 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3346842-B1 | STABLE INOCULANT COMPOSITIONS AND METHODS FOR PRODUCING SAME | NOVONESIS PLANT BIOSOLUTIONS AS (DK) | 2026-03-25 | — | — | EP | claimed |
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2026-03-24 | — | — | US | claimed |
| EP-4680720-A1 | OPTIMIZED PRODUCTION OF BRANCH POINT COMPOUNDS AND DERIVATIVES USING ALTERNATIVE ISOPENTENYL DIPHOSPHATE-SUPPLYING PATHWAYS | EvodiaBio ApS (DK) | 2026-01-21 | — | — | EP | claimed |
| US-12529077-B2 | Production of geranyl diphosphate-derived compounds | Københavns Universitet (DK) | 2026-01-20 | — | — | US | claimed |
| US-20250351853-A1 | FOOD COMPOSITION COMPRISING EQUOL AND PRODUCTION METHOD THEREFOR | DAICEL CORPORATION (JP) | 2025-11-20 | — | — | US | claimed |
| EP-3699174-B1 | COMPOSITION FOR PREVENTING OR TREATING TNF-RELATED DISEASES, CONTAINING DERIVATIVE AS ACTIVE INGREDIENT, AND METHOD FOR INHIBITING TNF ACTIVITY BY USING SAME | ILAB (KR) | 2025-11-12 | — | — | EP | claimed |
| US-20250277747-A1 | EQUOL MEASUREMENT KIT AND EQUOL MEASUREMENT METHOD | DAICEL CORPORATION (JP) | 2025-09-04 | — | — | US | claimed |
| US-20250250597-A1 | EQUOL MANUFACTURING METHOD | DAICEL CORPORATION (JP) | 2025-08-07 | — | — | US | claimed |
| US-12338475-B2 | Method for producing functional substance | DAICEL CORPORATION (JP) | 2025-06-24 | — | — | US | claimed |
| US-20250195452-A1 | ER-BETA ESTROGENIC COMPOUNDS AND METHODS OF USE | IATERION, INC. | 2025-06-19 | — | — | US | claimed |
| WO-1999036067-A1 | MODULATION OF HAIR GROWTH | THE GILLETTE COMPANY (US) | 1999-07-22 | — | — | WO | claimed |
| WO-1998056373-A1 | ISOFLAVONOIDS FOR TREATMENT AND PREVENTION OF AGING SKIN AND WRINKLES | GORBACH SHERWOOD L (US) | 1998-12-17 | — | — | WO | claimed |
| WO-1998052546-A1 | USE OF ISOFLAVONOIDS IN THE TREATMENT OR PREVENTION OF POSTPARTUM DEPRESSION | GORBACH SHERWOOD L (US) | 1998-11-26 | — | — | WO | claimed |
| WO-1998050026-A1 | TREATMENT OR PREVENTION OF MENOPAUSAL SYMPTOMS AND OSTEOPOROSIS | NOVOGEN INC (US) | 1998-11-12 | — | — | WO | claimed |
| WO-1998048790-A1 | USE OF GENISTEIN AND RELATED COMPOUNDS TO TREAT CERTAIN SEX HORMONE RELATED CONDITIONS | ANTICANCER, INC. (US) | 1998-11-05 | — | — | WO | claimed |
| WO-1998025588-A1 | ISOFLAVONOIDS FOR TREATMENT AND PREVENTION OF ALZHEIMER DEMENTIA AND REDUCED COGNITIVE FUNCTIONS | GORBACH SHERWOOD L (US) | 1998-06-18 | — | — | WO | claimed |
| WO-1998021946-A1 | COMPOSITION AND TREATMENT FOR PERSISTENT REPRODUCTIVE TRANSITION SYMPTOMS | INTERNUTRIA, INC. (US) | 1998-05-28 | — | — | WO | claimed |
| US-5733926-A | Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions | GORBACH SHERWOOD L (US) | 1998-03-31 | — | — | US | claimed |
| WO-1997046298-A1 | PROCESS AND EQUIPMENT FOR IMPLEMENTATION OF RECTIFICATION | HATOS PAL (HU) | 1997-12-11 | — | — | WO | claimed |
| US-5498631-A | ANTIESTROGENS USING ISOFLAVONOIDS | TUFTS UNIVERSITY SCHOOL OF MEDICINE (US) | 1996-03-12 | — | — | US | claimed |